Skip to main content
Fig. 1 | Applied Biological Chemistry

Fig. 1

From: RETRACTED ARTICLE: Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathway

Fig. 1

Evodiamine inhibits the proliferation of liver cancer cells a Chemical structure of evodiamine. b Viability of evodiamine treated PLHC-1 cells. c Viability of evodiamine treated HepG2 cells. d Viability of evodiamine treated THLE-2 cells. The results depicted that evodiamine inhibited the proliferation of the two liver cancer cell lines and with exceptionally low toxicity against the normal liver cell lines. The experiments were performed in triplicate and expressed as mean ± SD (*P < 0.05)

Back to article page